Dual implication of 2',3'-cyclic nucleotide 3' phosphodiesterase as major autoantigen and C3 complement-binding protein in the pathogenesis of multiple sclerosis
about
Expansion of antibody reactivity in the cerebrospinal fluid of multiple sclerosis patients - follow-up and clinical implicationsMyelin 2′,3′-Cyclic Nucleotide 3′-Phosphodiesterase: Active-Site Ligand Binding and Molecular ConformationExpression, purification, and initial characterization of different domains of recombinant mouse 2',3'-cyclic nucleotide 3'-phosphodiesterase, an enigmatic enzyme from the myelin sheath.Anti-DNA antibodies are a major component of the intrathecal B cell response in multiple sclerosis.Alpha actinin is specifically recognized by Multiple Sclerosis autoantibodies isolated using an N-glucosylated peptide epitopeIdentification of biomarkers in cerebrospinal fluid and serum of multiple sclerosis patients by immunoproteomics approach.B cells in multiple sclerosis.What do effective treatments for multiple sclerosis tell us about the molecular mechanisms involved in pathogenesis?Systems biology approaches for the study of multiple sclerosis.Protein array-based profiling of CSF identifies RBPJ as an autoantigen in multiple sclerosis.Role of CNPase in the oligodendrocytic extracellular 2',3'-cAMP-adenosine pathway.The myelin membrane-associated enzyme 2',3'-cyclic nucleotide 3'-phosphodiesterase: on a highway to structure and functionAutoimmune antigenic targets at the node of Ranvier in demyelinating disorders.Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis.Preparation of potential cell-permeant nucleoside-2',3'-cyclic phosphate precursors.Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study
P2860
Q24815840-0ECB7201-8560-480A-8110-9E4C56A4F6A5Q27677861-714CBB63-FE2E-4883-815B-318D07B9059AQ33533906-D3CCEB5F-9BD5-4B7D-95B0-2287D841DBDDQ34105027-AE25E862-7A42-41EF-9F7E-0D10B5BA4128Q34471650-1F72F54E-5562-4928-9C24-209AF0F7B162Q34835462-B67FC6BF-2967-46BA-ACE0-7971D47FDF36Q35650942-E49EA18F-CD50-4E94-A720-EC628768EDE5Q36396476-86B2723A-16AF-48E7-9ACC-57203B20ABECQ37174203-32A127F0-DB38-480E-BB11-738FF9631A49Q37463568-C04ED284-3539-4107-895E-12AD1B849A28Q37720630-17550B6E-32E6-443C-B106-043297D4020CQ38210119-D64D1021-A5AC-45A0-A3B6-4A9AD3DFFBE4Q38333532-A55BE69F-D56A-460B-88FD-4E0EF14B0995Q47357498-F0B42509-08C4-428E-AF14-26441D3AB6FCQ48190769-DE305BD2-62C2-485E-8EE8-719F3499774FQ59273880-818CBB4A-6D40-4823-9FD5-4B49539F8D2A
P2860
Dual implication of 2',3'-cyclic nucleotide 3' phosphodiesterase as major autoantigen and C3 complement-binding protein in the pathogenesis of multiple sclerosis
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 1998
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Dual implication of 2',3'-cycl ...... ogenesis of multiple sclerosis
@en
Dual implication of 2',3'-cycl ...... genesis of multiple sclerosis.
@nl
type
label
Dual implication of 2',3'-cycl ...... ogenesis of multiple sclerosis
@en
Dual implication of 2',3'-cycl ...... genesis of multiple sclerosis.
@nl
prefLabel
Dual implication of 2',3'-cycl ...... ogenesis of multiple sclerosis
@en
Dual implication of 2',3'-cycl ...... genesis of multiple sclerosis.
@nl
P2860
P356
P1476
Dual implication of 2',3'-cycl ...... ogenesis of multiple sclerosis
@en
P2093
P2860
P304
P356
10.1172/JCI1983
P407
P577
1998-05-01T00:00:00Z